Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis-Reference-Cited by-同舟云学术

Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

Published:2012-03 Issue:3 Volume:142 Page:442-452.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Liao Linda M.,Vaughan Thomas L.,Corley Douglas A.,Cook Michael B.,Casson Alan G.,Kamangar Farin,Abnet Christian C.,Risch Harvey A.,Giffen Carol,Freedman Neal D.,Chow Wong–Ho,Sadeghi Shahram,Pandeya Nirmala,Whiteman David C.,Murray Liam J.,Bernstein Leslie,Gammon Marilie D.,Wu Anna H.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference45 articles.

1. Trends in incidence of oesophageal and stomach cancer subtypes in Europe;Steevens;Eur J Gastroenterol Hepatol,2010

2. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005;Cook;Br J Cancer,2009

3. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

4. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States;Devesa;Cancer,1998

5. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas;Corley;J Natl Cancer Inst,2004

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening, Surveillance, and Prevention of Esophageal and Gastric Cancers;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

2. Molecular Biology and Clinical Management of Esophageal Adenocarcinoma;Cancers;2023-11-14

3. Low-dose acetylsalicylic acid for cancer prevention considering risk factors: a retrospective cohort study;Annals of Epidemiology;2023-08

4. Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett’s Esophagus;International Journal of Molecular Sciences;2023-07-11

5. Clinical and Oncological Impact of the Toll-like Receptor-3 and -4 in Esophageal and Gastro-esophageal Junction Adenocarcinoma;Anticancer Research;2023-06-23